← Back to Portfolio

Tizona Therapeutics

Tizona Therapeutics is a US immunotherapy company developing a pipeline of novel antibody therapeutics with potential in a broad range of cancers and autoimmune diseases. Tizona’s lead candidate is expected to start clinical trials in 2018 for cancer.  

LocationSouth San Francisco, California
CEOLuke Evnin, Executive Chairman
PartnerShelley Chu